{"type":"rich","title":"The Stats on a Dayvigo: A New Hypnotic [60 Sec Psych]","version":"1.0","provider_name":"Blubrry","provider_url":"https://blubrry.com","author_name":"The Carlat Psychiatry Podcast","html":"<iframe src=\"https://player.blubrry.com/?id=62381382\" title=\"Blubrry Podcast Player\" scrolling=\"no\" width=\"100%\" height=\"230\" frameborder=\"0\"></iframe>","height":"230","description":"Lemborexant/Dayvigo is the second in sleep med to join the orexin receptor antagonist family.","thumbnail_url":"https://www.thecarlatreport.com/wp-content/uploads/2020/06/CPP_60Sec_Dayvigo.png"}